US2002155167A1PendingUtilityA1
Self-setting calcium phosphate pastes and related products
Est. expiryMay 19, 2015(expired)· nominal 20-yr term from priority
A61F 2002/30062C04B 28/344A61F 2/30756C01B 25/325A61L 27/54C01B 25/32A61F 2002/30762C01B 25/16A61L 27/425A61F 2002/4648A61L 2400/06Y10S977/775A61L 24/02Y10S977/926C01B 25/321A61L 2300/414A61F 2310/00293A61F 2210/0004Y10S977/915A61L 27/12A61L 2300/452A61L 2300/252Y10S977/91A61L 27/58A61L 27/38A61K 9/2009Y10S977/70A61L 2300/406C04B 2111/00836A61L 2300/22A61L 2430/02A61F 2/28
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a novel process for producing a calcium phosphate cement or filler which hardens in a temperature dependent fashion in association with an endothermic reaction. In the reaction a limited amount of water is mixed with dry calcium phosphate precursors to produce a hydrated precursor paste. Hardening of the paste occurs rapidly at body temperature an is accompanied by the conversion of one or more of the reactants to poorly crystalline apatitic calcium phosphate. The hardened cements, fillers, growth matrices, orthopedic and delivery devices of the invention are rapidly resorbable and stimulate hard tissue growth and healing.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A formable paste, suitable for use as a bone substitution material, comprising:
a reactive amorphous calcium phosphate material having at least 90% amorphous character and characterized in that, when prepared 1:1 as a mixture with dicalcium phosphate dihydrate (DCPD) in water, wherein at least 20% by weight of said DCPD is retained by a 106μ sieve, the mixture remains injectable and formable for a time greater than about 60 minutes at about 18-19° C. and hardens at about 37° C. within about 10 to 60 minutes; a second calcium phosphate; and an aqueous-based fluid in an amount to provide a paste having a formable or injectable consistency at a temperature of about 18-19° C.
2 . The paste of claim 1 , wherein said amorphous calcium phosphate has a Ca/P molar ratio of about 1.1 to 1.65.
3 . The paste of claim 1 , wherein said second calcium phosphate has a Ca/P molar ration of less than or equal to 1.67.
4 . The paste of claim 1 , 2 , or 3 , further comprising a supplementary material selected to change a physical parameter of the paste or the hardened product, said parameter selected from the group consisting of strength, resorption time, adherence, injectability, frictional characteristics, release kinetics, tensile strength, hardness, fracture toughness, elasticity, imaging capability, flow properties and setting times.
5 . The paste of claim 1 , further comprising a therapeutic substance.
6 . The paste of claim 1 , wherein the fluid is selected from the group consisting of water, saline, non-phosphate buffer solutions, serum and tissue culture medium.
7 . The paste of claim 5 , wherein said therapeutic substance is selected from the group consisting of growth factors, antibiotics, anti-cancer agents, and analgesics.
8 . The paste of claim 1 , further comprising a crystallization inhibitor selected from the group consisting of carbonates, pyrophosphate, and magnesium.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.